FR2401147B1 - - Google Patents

Info

Publication number
FR2401147B1
FR2401147B1 FR7834071A FR7834071A FR2401147B1 FR 2401147 B1 FR2401147 B1 FR 2401147B1 FR 7834071 A FR7834071 A FR 7834071A FR 7834071 A FR7834071 A FR 7834071A FR 2401147 B1 FR2401147 B1 FR 2401147B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7834071A
Other versions
FR2401147A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2401147A1 publication Critical patent/FR2401147A1/fr
Application granted granted Critical
Publication of FR2401147B1 publication Critical patent/FR2401147B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7834071A 1977-07-22 1978-12-04 Nouvelles 4-pyrones substituees en positions 2, 3 et 6, utiles comme intermediaires chimiques dans la synthese de medicaments Granted FR2401147A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/818,043 US4132847A (en) 1977-07-22 1977-07-22 4-Pyrone prostaglandin antagonists

Publications (2)

Publication Number Publication Date
FR2401147A1 FR2401147A1 (fr) 1979-03-23
FR2401147B1 true FR2401147B1 (fr) 1981-08-28

Family

ID=25224503

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7821682A Granted FR2398067A1 (fr) 1977-07-22 1978-07-21 Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
FR7834071A Granted FR2401147A1 (fr) 1977-07-22 1978-12-04 Nouvelles 4-pyrones substituees en positions 2, 3 et 6, utiles comme intermediaires chimiques dans la synthese de medicaments

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7821682A Granted FR2398067A1 (fr) 1977-07-22 1978-07-21 Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant

Country Status (11)

Country Link
US (1) US4132847A (fr)
JP (3) JPS5814435B2 (fr)
BE (1) BE869166A (fr)
DE (1) DE2831761C2 (fr)
DK (1) DK148538C (fr)
FR (2) FR2398067A1 (fr)
GB (2) GB2055375B (fr)
IE (1) IE47035B1 (fr)
IT (1) IT1099579B (fr)
LU (1) LU80016A1 (fr)
NL (1) NL173750C (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0138523Y2 (fr) * 1981-01-31 1989-11-17
JPS5834046U (ja) * 1981-08-31 1983-03-05 株式会社明電舎 溶存酸素計
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
CA2113787A1 (fr) * 1993-01-29 1994-07-30 Nobuyuki Hamanaka Sulfonamides carbocycliques
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
WO1998050024A1 (fr) * 1997-05-09 1998-11-12 The Mount Sinai School Of Medicine Of The City University Of New York Traitement du glaucome a base de 8-iso-prostaglandines
US20020161026A1 (en) * 2000-11-07 2002-10-31 Paralkar Vishwas M. Combination therapies for the stimulation of bone growth
US20030220377A1 (en) * 2002-05-08 2003-11-27 Richard Chesworth Indole compounds and their use as estrogen agonists/antagonists
US20040002524A1 (en) * 2002-06-24 2004-01-01 Richard Chesworth Benzimidazole compounds and their use as estrogen agonists/antagonists
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
CA2677769C (fr) 2007-02-16 2016-01-19 Ono Pharmaceutical Co., Ltd. Agent therapeutique pour trouble de la miction
BR112020016256A2 (pt) 2018-02-21 2020-12-15 AI Therapeutics, Inc. Terapia de combinação com apilimod e agentes gluta-matérgicos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468916A (en) * 1966-11-01 1969-09-23 Pfizer & Co C 2-vinylpyromeconic acid

Also Published As

Publication number Publication date
IT1099579B (it) 1985-09-18
GB2055375B (en) 1982-08-11
FR2398067A1 (fr) 1979-02-16
NL7807803A (nl) 1979-01-24
GB2001639A (en) 1979-02-07
JPS54160382A (en) 1979-12-19
IT7825999A0 (it) 1978-07-21
DK326378A (da) 1979-01-23
DE2831761A1 (de) 1979-01-25
BE869166A (fr) 1979-01-22
US4132847A (en) 1979-01-02
JPS5730110B2 (fr) 1982-06-26
FR2398067B1 (fr) 1980-06-06
IE781471L (en) 1979-01-22
JPS5730109B2 (fr) 1982-06-26
JPS54160383A (en) 1979-12-19
DK148538C (da) 1986-01-13
GB2055375A (en) 1981-03-04
FR2401147A1 (fr) 1979-03-23
NL173750B (nl) 1983-10-03
LU80016A1 (fr) 1980-02-14
NL173750C (nl) 1984-03-01
GB2001639B (en) 1982-03-17
DE2831761C2 (de) 1984-12-13
IE47035B1 (en) 1983-11-30
JPS5814435B2 (ja) 1983-03-18
JPS5424876A (en) 1979-02-24
DK148538B (da) 1985-07-29

Similar Documents

Publication Publication Date Title
DE2819162C2 (fr)
CH643422B (fr)
FR2401147B1 (fr)
DE2852586C2 (fr)
AU3353778A (fr)
FR2342384B3 (fr)
FR2339288B3 (fr)
DE2739269B2 (fr)
AR210643A1 (fr)
AU495917B2 (fr)
FR2377040B1 (fr)
AU71461S (fr)
DK162377A (fr)
DK399477A (fr)
BE872973A (fr)
BE868323A (fr)
BG24331A1 (fr)
BG24713A1 (fr)
BG25808A1 (fr)
BG25809A1 (fr)
BG25810A1 (fr)
BG25811A1 (fr)
BG25812A1 (fr)
BG25813A1 (fr)
BG25815A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse